Case Study

AI-powered clinical intelligence for improved patient care

Learn how a rapidly growing ACO improved patient insights and expanded value-based care with Reveleer.
62%
Patients with new HCCs reviewed by providers
0.13
RAF uplift opportunity across patient populations
<2
Weeks retrieval time compared to months prior to Reveleer solution

Business challenge

An accountable care organization (ACO) planned to grow aggressively but needed to better understand the health status of patient populations acquired into its network to improve care.

Unfortunately, legacy processes relied too heavily on professional coders to manually review clinical documentation and struggled to scale.

Solution

Patient insights at the point of care

The ACO explored solutions and partnered with Reveleer in order to leverage our AI-enabled platform to improve the speed and accuracy of data acquisition and clinical review for over 70,000 patients.

Reveleer’s proprietary AI technology – EVE™ – synthesized and analyzed a nationwide network of clinical data from over 75 health information exchanges to create patient summaries with undiagnosed HCCs and supporting clinical documentation.

Reveleer then pushed these insights directly into the ACO’s provider workflows at the point of care for more precise clinical decision-making, such as earlier diagnosis detection.

70k
patients
75+
National and regional HIEs providing data
90%
of all hospitals

Clinical insights to improved patient outcomes

Using Reveleer's Clinical Intelligence suite and EVE™ helped supplement the ACO’s in-house data with Reveleer's data interoperability and AI-powered clinical insights. From the provider's perspective, the solution delivered timely, evidence-based clinical insights with a direct impact on patient outcomes while streamlining pre- and post-encounter workflows. By introducing Reveleer into their data and quality workflows, the ACO was able to both increase the speed of clinical review as well as uncover new clinical insights for 89% of patients, resulting in a 0.13 RAF uplift opportunity.

89%
Patients with new clinical data
62%
Had new HCCs reviewed by providers
0.13
RAF uplift opportunity across patient populations
< 2 weeks
Retrieval time compared to months prior to Reveleer solution

Next steps

Working with Revleer has increased the efficiency of retrieval and clinical review as well as delivered insights critical to improving patient care. The ACO continues to work with Reveleer to on-board new provider groups, arming them with clinical insights that create opportunities for early detection and better care. Providers can easily access insights to support their clinical decision-making, and the ACO can reach their value-based care goals by delivering highly effective care.